Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | CTSC | P53634 | 12/20 | 0.61 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.55 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43293 | 1.00 | CYP2C19 (0.70) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL43292 | 1.00 | CYP2C19 (0.70) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL7382497 | 0.98 | CYP2C19 (0.68) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL7382495 | 0.98 | CYP2C19 (0.68) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| Glycine SCHEMBL8101008 | 0.93 | CYP2C19 (0.62) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5236901 | 0.89 | CYP2C19 (0.57) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5236908 | 0.89 | CYP2C19 (0.57) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7252652 | 0.87 | CYP2C19 (0.54) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7252654 | 0.87 | CYP2C19 (0.54) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 | |
| Isoleucine SCHEMBL8483685 | 0.85 | CYP2C19 (0.53) | CYP2C19CTSCSLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496313-A | Calcium sensitive receptor agonist compounds and uses thereof | 北京拓界生物医药科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| US-20230041996-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF | BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD. (CN) | 2023-02-09 | — | — | US | claimed |
| EP-4091623-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF | Beijing Tuo Jie Biopharmaceutical Co. Ltd. (CN) | 2022-11-23 | — | — | EP | claimed |
| CN-114222578-A | Calcium-sensitive receptor agonist compounds and application thereof | 北京拓界生物医药科技有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-109022514-B | Method for preparing 3- (2-thienyl) -D-alanine | 南京工业大学 | 2021-05-11 | — | — | CN | claimed |
| EP-3339300-B1 | METHOD FOR PREPARING THIENYL ALANINE HAVING OPTICAL ACTIVITY | AMINOLOGICS CO LTD (KR) | 2020-08-12 | — | — | EP | claimed |
| US-10562879-B2 | Method for preparing thienyl alanine having optical activity | AMINOLOGICS CO., LTD. (KR) | 2020-02-18 | — | — | US | claimed |
| CN-109022514-A | Method for preparing 3- (2-thienyl) -D-alanine | 南京工业大学 | 2018-12-18 | — | — | CN | claimed |
| US-20180290996-A1 | METHOD FOR PREPARING THIENYL ALANINE HAVING OPTICAL ACTIVITY | AMINOLOGICS CO., LTD. (KR) | 2018-10-11 | — | — | US | claimed |
| EP-3339300-A1 | METHOD FOR PREPARING THIENYL ALANINE HAVING OPTICAL ACTIVITY | Aminologics Co., Ltd. (KR) | 2018-06-27 | — | — | EP | claimed |
| EP-2925340-A2 | PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS OF USE COMPRISING SELECTIVE AGONISTS OF MELANOCORTIN 1 RECEPTOR | University Of Cincinnati (US) | 2015-10-07 | — | — | EP | claimed |
| EP-2922565-A2 | SKIN CARE COMPOSITIONS AND METHODS COMPRISING SELECTIVE AGONISTS OF MELANOCORTIN 1 RECEPTOR | University Of Cincinnati (US) | 2015-09-30 | — | — | EP | claimed |
| EP-2462147-B1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2014-11-12 | — | — | EP | claimed |
| WO-2014081846-A2 | PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS OF USE COMPRISING SELECTIVE AGONISTS OF MELANOCORTIN 1 RECEPTOR | UNIVERSITY OF CINCINNATI (US) | 2014-05-30 | — | — | WO | claimed |
| WO-2014081845-A2 | SKIN CARE COMPOSITIONS AND METHODS COMPRISING SELECTIVE AGONISTS OF MELANOCORTIN 1 RECEPTOR | UNIVERSITY OF CINCINNATI (US) | 2014-05-30 | — | — | WO | claimed |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2012-08-09 | — | — | US | claimed |
| EP-1023324-A1 | TRIVALENT THROMBIN INHIBITOR | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2000-08-02 | — | — | EP | claimed |
| WO-1999019356-A1 | TRIVALENT THROMBIN INHIBITOR | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1999-04-22 | — | — | WO | claimed |
| EP-0656011-A1 | ANTI-INFLAMMATORY PEPTIDE ANALOGS AND TREATMENT TO INHIBIT VASCULAR LEAKAGE IN INJURED TISSUES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-06-07 | — | — | EP | claimed |
| WO-1994003489-A1 | ANTI-INFLAMMATORY PEPTIDE ANALOGS AND TREATMENT TO INHIBIT VASCULAR LEAKAGE IN INJURED TISSUES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-02-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | HTR2B, MC1R, HTR1A | CYP2C19 402/4885CTSC 1770/4885SLC1A3 2430/4885 |
| US-10562879-B2 | Method for preparing thienyl alanine having optical activity | ALAD, AADAT, THOP1 | CYP2C19 2392/4885CTSC 324/4885SLC1A3 1195/4885 |
| US-20180290996-A1 | METHOD FOR PREPARING THIENYL ALANINE HAVING OPTICAL ACTIVITY | ALAD, AADAT, THOP1 | CYP2C19 2392/4885CTSC 324/4885SLC1A3 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.